Gefitinib-loaded starch nanoparticles for battling lung cancer: Optimization by full factorial design and in vitro cytotoxicity evaluation

Lung cancer is the number one killer among all cancer types. For decades, clinicians have been using conventional chemotherapeutics, but they can’t rely on them alone anymore, because they poison bad cells and good cells as well. Researchers exploited nanotechnology as a potential tool to develop a...

Descripción completa

Detalles Bibliográficos
Autores principales: Amin, Haitham, Osman, Shaaban K., Mohammed, Ahmed M., Zayed, Gamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845129/
https://www.ncbi.nlm.nih.gov/pubmed/36685309
http://dx.doi.org/10.1016/j.jsps.2022.11.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845129/
https://www.ncbi.nlm.nih.gov/pubmed/36685309
http://dx.doi.org/10.1016/j.jsps.2022.11.004

Ejemplares similares